Corcept Therapeutics (CORT) Tops Q2 EPS by 2c
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 6/23/2026
- S&P 500, Nasdaq close lower, dragged by Alphabet and megacap tech; focus on Iran
- Oil settles down more 3% after US-Iran talks signal easing supply risks
- Micron surges 5.5% on blockbuster Anthropic AI deal ahead of earnings
- Alan Greenspan, influential former Federal Reserve chair, dies at 100
- Buy gold stocks as valuations are cheap amid macro tension: BofA
- Exclusive-China robot-hand-building unicorn Linkerbot targets $6 billion valuation
- Spain's ex-transport minister sentenced to 24 years for corruption
- Li Auto Inc. (LI) Breaks Ground on Chips R&D and Production Base
- Qtrex Quantum executives plan to buy up to 2M shares over 12 months
- China, US, UAE police arrest 276 telecom fraud suspects in Dubai
Corcept Therapeutics Announces Second Quarter 2016 Financial Results and Provides Corporate Update
August 2, 2016 4:05 PM EDTMENLO PARK, CA -- (Marketwired) -- 08/02/16 -- Corcept Therapeutics Incorporated (NASDAQ: CORT)
Second quarter revenue of $19.7 million, a 65 percent increase from the second quarter of 2015 Second quarter GAAP net income of $0.01 per share, compared to a GAAP net loss of $0.02 per share in the second quarter of 2015 Excluding non-cash expenses, second quarter non-GAAP net income of $0.03 per share, compared to non-GAAP net income of $0.00 per share in the second quarter of 2015 Cash balance at June 30 increases to $41.8 million Company reiterates its 2016 revenue guidance of $76-81 million... More